Exodus Point Capital Management, LP Avidity Biosciences, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.6 Billion
- Q4 2024
A detailed history of Exodus Point Capital Management, LP transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 33,844 shares of RNA stock, worth $984,183. This represents 0.01% of its overall portfolio holdings.
Number of Shares
33,844Holding current value
$984,183% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding RNA
# of Institutions
257Shares Held
108MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11MShares$321 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.43MShares$274 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$251 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.11MShares$236 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$231 Million3.76% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.52B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...